- Home
- CNDT vs WHWK Comparison
CNDT vs WHWK Comparison
Compare CNDT & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNDT | WHWK |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | 51000 | 23 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.7M | 187.4M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNDT | WHWK |
|---|---|---|
| Price | $1.55 | $3.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 1.1M | 685.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,042,000,000.00 | N/A |
| Revenue This Year | $2.01 | N/A |
| Revenue Next Year | $4.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $1.57 |
| 52 Week High | $2.98 | $5.50 |
Technical Indicators
Market Signals| Indicator | CNDT | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 53.58 | 44.88 |
| Support Level | $1.32 | $3.82 |
| Resistance Level | $1.61 | $4.38 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 57.86 | 21.40 |
Price Performance
Historical ComparisonAbout CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.